Literature DB >> 9854572

Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism.

E Lundgren1, S Ljunghall, G Akerström, J Hetta, H Mallmin, J Rastad.   

Abstract

BACKGROUND: Symptoms, signs, and treatment of mild primary hyperparathyroidism (HPT) are controversial.
METHODS: One hundred two patients with HPT and matched controls were recruited from 5202 females attending population-based mammography screening at age 55 to 75 years. Patients' total serum calcium averaged 10.40 +/- 0.564 mg/dL and intact serum parathyroid hormone 58 +/- 33 ng/L. All patients lacked knowledge of their disease. Questions revealed traditional symptoms of HPT in 24% of cases and 43% of controls (P = .01). All individuals underwent the same biochemical analyses, bone mass determination, and questionnaires on symptoms, illnesses, medications, and background variables.
RESULTS: Patients with HPT had more psychic complaints (P = .03 to .007) of lassitude, fatigue, irritability, and lack of sexual and emotional interests. They had lower bone density in total body, spine, and hip (P = .008 to .0004) and higher serum alkaline phosphatase, cholesterol (very-low-density lipoprotein), triglycerides (total, very-low-density lipoprotein), glucose, urate, and hemoglobin values (P = .02 to .0001). Patients visited physicians more often (P = .008) and had more antihypertensive therapy (P = .02).
CONCLUSIONS: Mild, "asymptomatic" HPT in patients unaware of their disorder displays significant psychic symptoms, bone loss, and risk factors of cardiovascular disease.

Entities:  

Mesh:

Year:  1998        PMID: 9854572

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  J Rastad
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  [Multiple endocrine neoplasia type 1].

Authors:  V Gudziol; A Schulze; J Gastmeier; T Zahnert
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

Review 3.  Recurrence of papillary thyroid cancer after optimized surgery.

Authors:  Clive S Grant
Journal:  Gland Surg       Date:  2015-02

Review 4.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

5.  Cardiovascular risk factors in primary hyperparathyroidism.

Authors:  R Luboshitzky; Y Chertok-Schaham; I Lavi; A Ishay
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

6.  Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study.

Authors:  Anders Bergenfelz; Anna Bladström; Mark Their; Erik Nordenström; Stig Valdemarsson; Johan Westerdahl
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

7.  Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism.

Authors:  Merih Baykan; Cihangir Erem; Turan Erdoğan; Arif Hacihasanoğlu; Omer Gedikli; Abdulkadir Kiriş; Mehmet Küçükosmanoğlu; Halil Onder Ersöz; Sükrü Celik
Journal:  Int J Cardiovasc Imaging       Date:  2006-10-12       Impact factor: 2.316

8.  Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.

Authors:  Petramala Luigi; Formicuccia Maria Chiara; Zinnamosca Laura; Marinelli Cristiano; Cilenti Giuseppina; Colangelo Luciano; Panzironi Giuseppe; Cerci Sabrina; Sciomer Susanna; Ciardi Antonio; Cavallaro Giuseppe; De Toma Giorgio; Letizia Claudio
Journal:  Int J Endocrinol       Date:  2012-06-07       Impact factor: 3.257

9.  Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study.

Authors:  Sophie Norenstedt; Ylva Pernow; Kerstin Brismar; Maria Sääf; Ayla Ekip; Fredrik Granath; Jan Zedenius; Inga-Lena Nilsson
Journal:  Eur J Endocrinol       Date:  2013-10-21       Impact factor: 6.664

10.  Neuropsychological features in primary hyperparathyroidism: a prospective study.

Authors:  Marcella D Walker; Donald J McMahon; William B Inabnet; Ronald M Lazar; Ijeoma Brown; Susan Vardy; Felicia Cosman; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.